Search results
Search for "paclitaxel" in Full Text gives 31 result(s) in Beilstein Journal of Nanotechnology.
Nanoscale isoindigo-carriers: self-assembly and tunable properties
Beilstein J. Nanotechnol. 2017, 8, 313–324, doi:10.3762/bjnano.8.34
- (paclitaxel) on the therapeutic efficacy was also shown [64]. As seen in Figure 2a, the size of SIPs of 2h is ca. 300 nm, which is comparable with that determined by DLS (Figure 2c). The morphology of aggregates resembles branched elongated structures consisting of small particles of 2–3 nm (Figure 2b). The
Nanofibers for drug delivery – incorporation and release of model molecules, influence of molecular weight and polymer structure
Beilstein J. Nanotechnol. 2015, 6, 1939–1945, doi:10.3762/bjnano.6.198
- , solvent or tablet excipient. Apart from these applications the PEG has significant effect on the drug release. It has been shown that addition of PEG molecules is an efficient way to modify the release of hydrophobic paclitaxel from poly(lactic acid-co-glycolic acid) matrix [25] or proteins from lipidic
- release of potentially incorporated drug [27][28]. Especially, the addition of PEG has a great impact in systems with hydrophobic drugs (e.g., cyclosporine, paclitaxel) in which it can overcome the complication with homogenous dispersion of drug in the polymer matrix and mainly can facilitate the release
Experiences in supporting the structured collection of cancer nanotechnology data using caNanoLab
Beilstein J. Nanotechnol. 2015, 6, 1580–1593, doi:10.3762/bjnano.6.161
- triazine dendrimer with paclitaxel. Composition information captures properties inherent to the dendrimer (e.g., generation), as well as properties inherent to several particle types (e.g., chemical name, molecular formula). Bottom diagram highlights high level concepts and properties pertaining to
Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy
Beilstein J. Nanotechnol. 2015, 6, 546–558, doi:10.3762/bjnano.6.57
- after 24 h. Again, Liong et al. [56] reported the synthesis of multifunctional silica nanospheres with magnetic iron oxide NPs, luminescent fluorescein isothiocyanate (FITC) and camptothecin or paclitaxel as anti-cancer drug molecules entrapped inside the core. These nanospheres were finally modified
Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl–dextran–MMA graft copolymer and paclitaxel used as an artificial enzyme
Beilstein J. Nanotechnol. 2014, 5, 2293–2307, doi:10.3762/bjnano.5.238
- complex that was used as an artificial enzyme against multi-drug-resistant cancer cells was confirmed. A complex of diethylaminoethyl–dextran–methacrylic acid methylester copolymer (DDMC)/paclitaxel (PTX), obtained with PTX as the guest and DDMC as the host, formed a nanoparticle 50–300 nm in size. This
- cancer cells; paclitaxel; supramolecular complex; Review Introduction As a means of delivering a drug to a target effectively, the enhanced permeation and retention (EPR) effect and reticuloendothelial system (RES) were enabled by using a polymer drug delivery system (DDS), and it is thought to
- ligands from an active center. Supramolecules have been suggested for the use as artificial enzymes [9]. The supramolecular diethylaminoethyl (DEAE)–dextran–methacrylic acid methylester (MMA) copolymer (DDMC)/paclitaxel (PTX) complex, which is expected to inhibit drug-induced resistance by allosteric
In vitro toxicity and bioimaging studies of gold nanorods formulations coated with biofunctional thiol-PEG molecules and Pluronic block copolymers
Beilstein J. Nanotechnol. 2014, 5, 546–553, doi:10.3762/bjnano.5.64
- or antigens to be linked to their surface for targeted delivery and imaging [16][17]. More importantly, one is not able to use CTAB-coated AuNRs as a carrier for drug delivery of water insoluble anti-cancer agents (e.g., doxorubicin, paclitaxel) to the cancerous area since their surface is
Other Beilstein-Institut Open Science Activities
